- Home
- MNPR vs ASC Comparison
MNPR vs ASC Comparison
Compare MNPR & ASC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNPR | ASC |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 531.6M | 497.7M |
| IPO Year | 2019 | 2013 |
Fundamental Metrics
Financial Performance| Metric | MNPR | ASC |
|---|---|---|
| Price | $75.05 | $11.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $97.83 | $13.67 |
| AVG Volume (30 Days) | 163.8K | ★ 592.0K |
| Earning Date | 11-13-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $309,326,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $21.00 | $8.32 |
| 52 Week High | $105.00 | $13.85 |
Technical Indicators
Market Signals| Indicator | MNPR | ASC |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 32.13 |
| Support Level | $74.51 | $11.75 |
| Resistance Level | $79.31 | $12.41 |
| Average True Range (ATR) | 6.38 | 0.31 |
| MACD | -0.93 | -0.15 |
| Stochastic Oscillator | 6.10 | 6.14 |
Price Performance
Historical ComparisonAbout MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About ASC Ardmore Shipping Corporation
Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.